We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.68B
Cap. Flow %
-5.1%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
526
HCA Healthcare
HCA
$91.8B
$5.07M 0.02%
16,898
-20,175
-54% -$7.05M
TDY icon
527
Teledyne Technologies
TDY
$27.7B
$5.02M 0.02%
10,815
+4,911
+83% +$2.29M
FAF icon
528
First American
FAF
$7.44B
$5M 0.02%
+80,125
New +$5.23M
REZI icon
529
Resideo Technologies
REZI
$2.84B
$4.98M 0.02%
216,259
+5,831
+3% +$137K
PRIM icon
530
Primoris Services
PRIM
$4.13B
$4.98M 0.02%
+65,191
New +$4.76M
LDOS icon
531
Leidos
LDOS
$16.2B
$4.95M 0.02%
34,379
-86,301
-72% -$14.4M
KFY icon
532
Korn Ferry
KFY
$4.25B
$4.9M 0.01%
72,684
+1,827
+3% +$133K
BAH icon
533
Booz Allen Hamilton
BAH
$9.63B
$4.9M 0.01%
38,067
-7,204
-16% -$1.12M
USB icon
534
US Bancorp
USB
$96.9B
$4.9M 0.01%
102,380
+67,759
+196% +$3.33M
PHM icon
535
Pultegroup
PHM
$22.8B
$4.85M 0.01%
44,552
-11,582
-21% -$1.5M
CROX icon
536
Crocs
CROX
$5.34B
$4.84M 0.01%
44,202
-3,351
-7% -$390K
MTB icon
537
M&T Bank
MTB
$34B
$4.78M 0.01%
25,438
+23,764
+1,420% +$4.72M
BFH icon
538
Bread Financial
BFH
$4.14B
$4.76M 0.01%
77,897
+7,871
+11% +$445K
WRB icon
539
W.R. Berkley
WRB
$26.5B
$4.75M 0.01%
81,130
+18,705
+30% +$1.12M
JAZZ icon
540
Jazz Pharmaceuticals
JAZZ
$15.6B
$4.75M 0.01%
+38,543
New +$4.54M
YETI icon
541
Yeti Holdings
YETI
$2.88B
$4.7M 0.01%
121,988
SPSC icon
542
SPS Commerce
SPSC
$2.95B
$4.7M 0.01%
25,519
-2,571
-9% -$482K
L icon
543
Loews
L
$22.3B
$4.68M 0.01%
55,286
-21,018
-28% -$1.73M
CLDX icon
544
Celldex Therapeutics
CLDX
$3.02B
$4.68M 0.01%
185,040
-294
-0.2% -$7.99K
GPC icon
545
Genuine Parts
GPC
$18.1B
$4.67M 0.01%
40,031
+6,565
+20% +$819K
ROK icon
546
Rockwell Automation
ROK
$46.3B
$4.64M 0.01%
16,221
+13,834
+580% +$3.89M
SRRK icon
547
Scholar Rock
SRRK
$6.09B
$4.59M 0.01%
106,094
-266,261
-72% -$8.67M
PLRX icon
548
Pliant Therapeutics
PLRX
$69.4M
$4.57M 0.01%
346,941
-546
-0.2% -$7.46K
BOX icon
549
Box
BOX
$4.77B
$4.56M 0.01%
144,167
+134,101
+1,332% +$4.4M
VRNT
550
DELISTED
Verint Systems
VRNT
$4.55M 0.01%
165,633
+13,199
+9% +$330K

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.68B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.